Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Crying and spilling--time to stop the overmedicalisation of normal infant behaviour.

Hudson B, Alderton A, Doocey C, Nicholson D, Toop L, Day AS.

N Z Med J. 2012 Dec 14;125(1367):119-26. Review.

PMID:
23321888
2.

Proton pump inhibitor utilization patterns in infants.

Barron JJ, Tan H, Spalding J, Bakst AW, Singer J.

J Pediatr Gastroenterol Nutr. 2007 Oct;45(4):421-7.

PMID:
18030207
3.

Natural history and familial relationships of infant spilling to 9 years of age.

Martin AJ, Pratt N, Kennedy JD, Ryan P, Ruffin RE, Miles H, Marley J.

Pediatrics. 2002 Jun;109(6):1061-7.

PMID:
12042543
4.

Proton pump inhibitors for irritable infants.

Smith CH, Israel DM, Schreiber R, Goldman RD.

Can Fam Physician. 2013 Feb;59(2):153-6.

5.

Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy.

Romano C, Chiaro A, Comito D, Loddo I, Ferrau V.

Curr Clin Pharmacol. 2011 Feb;6(1):41-7. Review.

PMID:
21235462
6.

[Omeprazole of limited value in crying babies].

Blokpoel RG, Broos N, de Jong-van den Berg LT, de Vries TW.

Ned Tijdschr Geneeskd. 2010;154:A1850. Dutch.

PMID:
20719016
7.

[Adverse events associated with long-term use of proton pump inhibitors].

Reimer C, Bytzer P.

Ugeskr Laeger. 2012 Sep 24;174(39):2289-93. Danish.

PMID:
23006222
8.

Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.

Miner PB Jr, McKean LA, Gibb RD, Erasala GN, Ramsey DL, McRorie JW.

Aliment Pharmacol Ther. 2010 Apr;31(8):846-51. doi: 10.1111/j.1365-2036.2010.04258.x. Epub 2010 Feb 8.

9.

A review of omeprazole use in the treatment of acid-related disorders in children.

Zimmermann AE, Walters JK, Katona BG, Souney PE, Levine D.

Clin Ther. 2001 May;23(5):660-79; discussion 645. Review.

PMID:
11394727
10.

Over-prescription of acid-suppressing medications in infants: how it came about, why it's wrong, and what to do about it.

Hassall E.

J Pediatr. 2012 Feb;160(2):193-8. doi: 10.1016/j.jpeds.2011.08.067. Epub 2011 Oct 22. No abstract available.

PMID:
22018908
11.

[Safety of proton pump inhibitors for long-term application].

Kuipers E.

Eksp Klin Gastroenterol. 2006;(4):48-52. Review. Russian. No abstract available.

PMID:
17269424
12.

Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.

Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, Passariello A, Manguso F, Morelli L, Guarino A; Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP).

Pediatrics. 2006 May;117(5):e817-20.

PMID:
16651285
13.
14.

Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.

Bohmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Tuynman HA, Voskuil JH, Devillé WL, Meuwissen SG.

Am J Gastroenterol. 1997 Sep;92(9):1475-9.

PMID:
9317066
15.

Is there a dark side to long-term proton pump inhibitor therapy?

Nealis TB, Howden CW.

Am J Ther. 2008 Nov-Dec;15(6):536-42. doi: 10.1097/MJT.0b013e31817149bf. Review.

PMID:
19127138
16.

Effect of long-term, continuous versus alternate-day omeprazole therapy on serum gastrin in patients treated for reflux esophagitis.

Ligumsky M, Lysy J, Siguencia G, Friedlander Y.

J Clin Gastroenterol. 2001 Jul;33(1):32-5.

PMID:
11418787
17.
18.

[Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients].

Lundell L.

Lakartidningen. 2009 Feb 18-24;106(8):502-5. Swedish. No abstract available.

PMID:
19350782
19.

Failure of proton pump inhibitors to treat GERD in neonates and infants: a question of drug, diagnosis, or design.

Shakhnovich V, Ward RM, Kearns GL.

Clin Pharmacol Ther. 2012 Sep;92(3):388-92. doi: 10.1038/clpt.2012.86. Epub 2012 Jul 18. Review. No abstract available.

PMID:
22805424
20.

Underutilization of gastroprotective drugs in patients receiving non-steroidal anti-inflammatory drugs.

Thiéfin G, Schwalm MS.

Dig Liver Dis. 2011 Mar;43(3):209-14. doi: 10.1016/j.dld.2010.09.009. Epub 2010 Nov 3.

PMID:
21051300

Supplemental Content

Support Center